Correlation Between GlaxoSmithKline PLC and Quantified Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Quantified Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Quantified Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Quantified Common Ground, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Quantified Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Quantified Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Quantified Common.

Diversification Opportunities for GlaxoSmithKline PLC and Quantified Common

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Quantified is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Quantified Common Ground in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantified Common Ground and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Quantified Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantified Common Ground has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Quantified Common go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Quantified Common

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Quantified Common. In addition to that, GlaxoSmithKline PLC is 1.53 times more volatile than Quantified Common Ground. It trades about -0.3 of its total potential returns per unit of risk. Quantified Common Ground is currently generating about 0.19 per unit of volatility. If you would invest  1,614  in Quantified Common Ground on August 30, 2024 and sell it today you would earn a total of  60.00  from holding Quantified Common Ground or generate 3.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Quantified Common Ground

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Quantified Common Ground 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Quantified Common Ground are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Quantified Common is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Quantified Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Quantified Common

The main advantage of trading using opposite GlaxoSmithKline PLC and Quantified Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Quantified Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantified Common will offset losses from the drop in Quantified Common's long position.
The idea behind GlaxoSmithKline PLC ADR and Quantified Common Ground pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum